TGFB1 and pulmonary fibrosis: These results from human IPF samples, BLM‐challenged mice, and TGF‐β1‐treated AT2 cells consistently demonstrate disrupted Hcy metabolism and subsequent Hcy accumulation as hallmark features of pulmonary fibrosis.